오가노이드 및 스페로이드 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Organoids And Spheroids Market is presumed to reach the market size of nearly USD 5444.06 MN by 2032 from USD 780.92 MN in 2023 with a CAGR of 24.08% under the study period 2024 - 2032.

Organoids and spheroids are three-dimensional cell cultures that mimic the structure & function of organs or tissues in a laboratory setting. Organoids are self-organized, miniature versions of organs, while spheroids are cell aggregates with spherical shapes. These models are used in biomedical research to study organ development, disease progression, and drug testing. They provide more accurate representations of in vivo conditions than traditional cell cultures, offering insights into complex biological processes and supporting advancements in personalized medicine.

MARKET DYNAMICS

The organoids and spheroids market is driven by advancements in regenerative medicine, drug discovery, and personalized medicine, leveraging three-dimensional (3D) cell culture technologies. The demand for more physiologically relevant models in biomedical research, drug screening, and disease modeling contributes market growth. The potential of these 3D cell culture systems to recapitulate tissue-specific functions, simulate complex interactions, and offer a closer representation of in vivo conditions fuels their adoption in the life sciences and pharmaceutical industries. Additionally, the focus on reducing reliance on animal models and the need for personalized treatment approaches drive the development and utilization of organoids and spheroids. Technological innovations, including biofabrication techniques and the integration of advanced imaging and analysis tools, further support the expanding applications of organoids and spheroids in biomedical research and therapeutic development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organoids and spheroids. The growth and trends of organoids and spheroids industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the organoids and spheroids market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells)
• Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells)

By Application

• Developmental Biology
• Personalized Medicine
• Regenerative Medicine
• Disease Pathology Studies
• Drug Toxicity & Efficacy Testing

By End-Use

• Biotechnology And Pharmaceutical Industries
• Academic & Research Institutes
• Hospitals And Diagnostic Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Organoids And Spheroids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
• Global Organoids And Spheroids Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organoids And Spheroids market include 3D Biomatrix, 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Cellesce Ltd, Corning Incorporated, Greiner Bio-One, Hubrecht Organoid Technology (HUB), InSphero, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc., Thermo Fisher Scientific, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ORGANOIDS AND SPHEROIDS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 Organoids (Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), Method (General Submerged Method For Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (Ali) Method For Organoid Culture, Clonal Organoids From Lgr5+ Cells, Brain And Retina Organoid Formation Protocol, Others), Source (Primary Tissues, Stem Cells) Historic and Forecast Sales by Regions
• 5.5 Spheroids (Type (Multicellular Tumor Spheroids (Mcts), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Source (Cell Line, Primary Cell, Ipscs Derived Cells) Historic and Forecast Sales by Regions

6 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Developmental Biology Historic and Forecast Sales by Regions
• 6.5 Personalized Medicine Historic and Forecast Sales by Regions
• 6.6 Regenerative Medicine Historic and Forecast Sales by Regions
• 6.7 Disease Pathology Studies Historic and Forecast Sales by Regions
• 6.8 Drug Toxicity & Efficacy Testing Historic and Forecast Sales by Regions

7 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Biotechnology and Pharmaceutical Industries Historic and Forecast Sales by Regions
• 7.5 Academic & Research Institutes Historic and Forecast Sales by Regions
• 7.6 Hospitals and Diagnostic Centers Historic and Forecast Sales by Regions

8 . GLOBAL ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ORGANOIDS AND SPHEROIDS COMPANIES

• 9.1. Organoids And Spheroids Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ORGANOIDS AND SPHEROIDS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. 3D Biomatrix
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. 3D Biotek LLC
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. AMS Biotechnology (Europe) Limited
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Cellesce Ltd
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Corning Incorporated
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Greiner Bio-One
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Hubrecht Organoid Technology (HUB)
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. InSphero
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Lonza
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Merck KGaA
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Prellis Biologics
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. STEMCELL Technologies Inc.
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Thermo Fisher Scientific Inc.
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies